Lu Cong, Song Chao, Han Qingkun, Jing Xuebing
Department of Hematology, Zibo Central Hospital, Zibo City, 255000, PR. China.
Department of Pathology, Zibo Central Hospital, Zibo City, 255000, PR. China.
Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022047. doi: 10.4084/MJHID.2022.047. eCollection 2022.
It was reported that circular RNA (circRNA) circCTNNA1 plays an oncogenic role in colorectal cancer, while its role in mantle cell lymphoma (MCL) is unknown. This study aimed to explore the role of circCTNNA1 in MCL.
Samples of B lymphocytes were collected from 56 MCL patients and 56 healthy controls. The expression of circCTNNA1 and miR-34a in these samples were determined by RT-qPCR. The direct interaction between circCTNNA1 and miR-34a in MCL cells was detected using RNA-RNA pulldown assay. Overexpression assays were performed to study the interactions between circCTNNA1 and miR-34a. Cell proliferation was assessed with BrdU assay.
The results showed that circCTNNA1 was upregulated in MCL and high expression levels of circCTNNA1 predicted the poor survival of MCL patients. MiR-34a was downregulated in MCL and inversely correlated with circCTNNA1. CircCTNNA1 was predicted to interact with miR-34a, and the interaction between them was confirmed by RNA pull-down assay. Interestingly, overexpression of circCTNNA1 and miR-34a did not affect the expression of each other. Cell proliferation analysis showed that overexpression of circCTNNA1 reversed the inhibitory effects of overexpression of miR-34a on cell proliferation.
Upregulation of circCTNNA1 in MCL predicts poor survival of patients and it may sponge miR-34a to promote cancer cell proliferation.
据报道,环状RNA(circRNA)circCTNNA1在结直肠癌中发挥致癌作用,而其在套细胞淋巴瘤(MCL)中的作用尚不清楚。本研究旨在探讨circCTNNA1在MCL中的作用。
收集56例MCL患者和56例健康对照者的B淋巴细胞样本。采用RT-qPCR检测这些样本中circCTNNA1和miR-34a的表达。使用RNA-RNA下拉试验检测MCL细胞中circCTNNA1与miR-34a之间的直接相互作用。进行过表达试验以研究circCTNNA1与miR-34a之间的相互作用。用BrdU试验评估细胞增殖。
结果显示,circCTNNA1在MCL中上调,circCTNNA1的高表达水平预示着MCL患者的不良生存。miR-34a在MCL中下调,且与circCTNNA1呈负相关。预测circCTNNA1与miR-34a相互作用,并通过RNA下拉试验证实了它们之间的相互作用。有趣的是,circCTNNA1和miR-34a的过表达并不影响彼此的表达。细胞增殖分析表明,circCTNNA1的过表达逆转了miR-34a过表达对细胞增殖的抑制作用。
MCL中circCTNNA1的上调预示患者生存不良,它可能通过吸附miR-34a促进癌细胞增殖。